WHO Still Planning Biosimilar Naming Guidance, Gives Update On Prequalification Pilot

 
• By Ian Schofield
  
Door
The WHO hasn't closed the door on biologic naming guidance
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Biosimilars & Generics